(3R,4S)-1-(4-FLUOROPHENYL)-3-(3-(4-FLUOROPHENYL)-3-OXOPROPYL)-4-(4-HYDROXYPHENYL)AZETIDIN-2-ONE, 95%, 1mg

trans-4-(Boc-Amino)cyclohexyl methanesulfonate, 80.0%, 250mg

(S)-N-((3-(3-Fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methyl)acetamide, 95.0%, 10g

(2S,4R)-1-(tert-Butoxycarbonyl)-4-(3-chlorobenzyl)pyrrolidine-2-carboxylic acid, 95.0%, 500mg

butyl[(2-ethoxyphenyl)methyl]amine, 95.0%, 10g

(S)-tert-Butyl 3-(methoxymethyl)piperazine-1-carboxylate, 95.0%, 5g

Arsenazo III, mínimo 85%, pa, 5 g, envase de vidrio

(S)-2-Amino-3-(7-fluoro-1H-indol-3-yl)propanoic acid, 95%, 1g

TERT-BUTYL (2R,4S)-2-(HYDROXYMETHYL)-4-METHOXYPYRROLIDINE-1-CARBOXYLATE, 95.0%, 1g

(1S,4R)-Methyl 4-((tert-butoxycarbonyl)amino)cyclopent-2-enecarboxylate, 95.0%, 10g

Viales Headspace ROTILABO® con borde rebordeado ND20, fondo redondeado, vidrio transparente, borde biselado, 20 ml, 100 pieza(s)

(S)-1-(2-(2-Aminoethoxy)-5-chloropyridin-3-yl)-3-(2-chloro-7-(1-methoxyethyl)pyrazolo[1,5-a]pyrimidin-6-yl)urea hydrochloride, 98%, 25mg

(S)-tert-Butyl 3-methyl-4-((2-nitrophenyl)sulfonyl)-1,4-diazepane-1-carboxylate, 97.0%, 1g